MedPath
HSA Approval

K. U. DACTINOMYCIN FOR INJECTION 0.5 mg/vial

SIN10989P

K. U. DACTINOMYCIN FOR INJECTION 0.5 mg/vial

K. U. DACTINOMYCIN FOR INJECTION 0.5 mg/vial

June 25, 1999

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

L01DA01

dactinomycin

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

KOREA UNITED PHARMACEUTICAL INC

Active Ingredients

DACTINOMYCIN

0.5 mg/vial

Dactinomycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

K. U. DACTINOMYCIN FOR INJECTION 0.5 mg/vial - HSA Approval | MedPath